Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
<p>Abstract</p> <p>Background</p> <p>Due to increasing drug resistance, artemisinin-based combination chemotherapy (ACT) has become the first-line treatment of falciparum malaria in many endemic countries. However, irreversible ototoxicity associated with artemether/lum...
Main Authors: | Krause Eike, Girma Tsinuel, Mamo Yoseph, Berens-Riha Nicole, Miranda Isabel, Eshetu Teferi, Gürkov Robert, Schmidt Michael, Hempel John-Martin, Löscher Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/7/1/179 |
Similar Items
-
Open-label trial with artemether-lumefantrine against uncomplicated <it>Plasmodium falciparum</it> malaria three years after its broad introduction in Jimma Zone, Ethiopia
by: Eshetu Teferi, et al.
Published: (2012-07-01) -
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
by: van Vugt, M, et al.
Published: (2000) -
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: Mcgready, R, et al.
Published: (2006) -
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: McGready, R, et al.
Published: (2009) -
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
by: Dev Vas, et al.
Published: (2009-05-01)